Ondansetron: all 232 studies that test it
Page 3 of 3. Open to participants first (27), then studies with results posted, then the rest; newest registration first within each.
- Uncomplicated Nausea and Vomiting in the Emergency DepartmentCompletedNCT00778011Phase 4
- Combined Pharmacotherapies for AlcoholismCompletedNCT00768508Phase 3
- Ondansetron for the Treatment of IBS With Diarrhoea (IBS-D)CompletedNCT00745004Phase 4
- Combination Antiemetic Regimen for Prevention of PONV in Breast Surgery PatientsCompletedNCT00738621Phase 4
- Efficacy Study of IV Fluids Only vs Ondansetron to Treat DehydrationWithdrawnNCT00691275Not applicable
- Ondansetron With Olanzapine for the Treatment of Alcohol Dependence: A Preliminary Clinical TrialCompletedNCT00678457Phase 2
- Bioavailability Study of Ondansetron 16 mg Orally Disintegrating Tablets Under Fasting ConditionsCompletedNCT00659685Phase 1
- Bioavailability Study of Ondansetron 24 mg Orally Disintegrating Tablets Under Fasting ConditionsCompletedNCT00659074Phase 1
- Bioavailability Study of Ondansetron Orally Disintegrating Tablets Under Fasting ConditionsCompletedNCT00654277Phase 1
- Bioavailability Study of Ondansetron Orally Disintegrating Tablets Under Fed ConditionsCompletedNCT00653458Phase 1
- Fasting Study of Ondansetron Tablets 24 mg and Zofran® Tablets 24 mgCompletedNCT00649532Phase 1
- Food Study of Ondansetron Tablets 24 mg and Zofran® Tablets 24 mgCompletedNCT00648583Phase 1
- The Effects of the Anti Nausea Drugs Droperidol and Ondansetron on the Way the Heart Recovers Between BeatsCompletedNCT00624208Not applicable
- Pharmacotherapy for HIV+ Stimulant Dependent IndividualsStatus unknownNCT00599573Not applicable
- Aprepitant or Ondansetron in Treating Nausea and Vomiting Caused By Opioids in Patients With CancerWithdrawnNCT00499668Not applicable
- A Study to Assess the Safety & Interaction Between GW679769, Dexamethasone, & Ondansetron When Taken by Healthy AdultsCompletedNCT00437229Phase 1
- A RCT of Ondansetron and Promethazine in the Treatment of Nausea and Vomiting in the Emergency DepartmentCompletedNCT00429832Phase 4
- Ondansetron Reduce Vomiting Associated With Ketamine PSACompletedNCT00387556Not applicable
- Pharmacological Treatment for AlcoholismCompletedNCT00382642Phase 3
- Toxicity Substudy of Evaluation of Subcutaneous Proleukin in a Randomised International Trial (ESPRIT): TOXIL-2 SubstudyTerminatedNCT00147355Phase 3
- Post Burn Pruritus Study in Patients Undergoing Wound HealingCompletedNCT00137202Not applicable
- A Study To Evaluate An NK-1 Antiemetic For The Prevention Of Post Operative Nausea And VomitingCompletedNCT00108095Phase 2
- Study Of Prevention of Chemo-Induced Nausea and Vomiting Caused By Moderately Emetogenic ChemotherapyCompletedNCT00104403Phase 2
- Ondansetron for the Treatment of Methamphetamine Dependence - 1CompletedNCT00040053Phase 2
- Ondansetron for the Treatment of Cocaine Dependence - 1CompletedNCT00033085Phase 2
- Combined Pharmacotherapies for Alcoholism (Naltrexone/Ondansetron)CompletedNCT00027079Phase 2
- Ondansetron With/Out Dexamethasone to Prevent Vomiting in Patients Receiving Radiation to the Upper AbdomenCompletedNCT00016380Phase 3
- Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer TreatmentCompletedNCT00006348Phase 3
- Alcohol Dependency Study: Combining Medication Treatment for AlcoholismStatus unknownNCT00006205Phase 2
- Patient Education in Preventing Nausea and Vomiting in Cancer Patients Receiving ChemotherapyCompletedNCT00005994Not applicable
- Ondansetron Treatment for AlcoholismCompletedNCT00000443Phase 2
- Role of Metabolites in Nicotine Dependence (3) - 6CompletedNCT00000289Phase 2